Stock BMY BRISTOL-MYERS SQUIBB COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Valuation Bristol-Myers Squibb Company

Equities

BMY

US1101221083

Pharmaceuticals

Real-time Estimate Cboe BZX
Other stock markets
 12:22:35 2025-01-22 pm EST 		5-day change 1st Jan Change
56.64 USD -0.70% Intraday chart for Bristol-Myers Squibb Company +1.22% +0.05%
Jan. 17 Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks MT
Jan. 17 Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks MT

Company Valuation: Bristol-Myers Squibb Company

Data adjusted to current consolidation scope
Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 150,473 140,172 138,395 159,703 104,403 115,687 115,687 -
Change - -6.85% -1.27% 15.4% -34.63% 10.81% 0% -
Enterprise Value (EV) 1 181,813 174,584 165,982 189,770 131,531 153,431 145,236 138,276
Change - -3.98% -4.93% 14.33% -30.69% 16.65% -5.34% -4.79%
P/E ratio - -15.5x 20x 24.4x 13.3x -18.4x 11.8x 11.7x
PBR 2.12x 3.7x 3.73x 5.02x 3.48x 6.74x 5.7x 5.18x
PEG - - -0x -4.48x 0.4x 0x -0x 7.38x
Capitalization / Revenue 5.76x 3.3x 2.98x 3.46x 2.32x 2.44x 2.48x 2.63x
EV / Revenue 6.95x 4.11x 3.58x 4.11x 2.92x 3.23x 3.12x 3.15x
EV / EBITDA 18.3x 9.64x 8.1x 9.83x 7.52x 27.8x 8.12x 8.91x
EV / EBIT 22.2x 10x 8.37x 9.76x 7.84x 32.5x 8.55x 8.99x
EV / FCF 25.1x 13.1x 10.9x 15.9x 10.4x 10.1x 8.56x 9.16x
FCF Yield 3.98% 7.62% 9.18% 6.3% 9.62% 9.86% 11.7% 10.9%
Dividend per Share 2 1.68 1.84 2.01 2.19 2.31 2.388 2.458 2.536
Rate of return 2.62% 2.97% 3.22% 3.04% 4.5% 4.19% 4.31% 4.45%
EPS 2 - -3.99 3.12 2.95 3.86 -3.1 4.817 4.894
Distribution rate - -46.1% 64.4% 74.2% 59.8% -77.1% 51% 51.8%
Net sales 1 26,145 42,518 46,385 46,159 45,006 47,459 46,572 43,915
EBITDA 1 9,945 18,118 20,493 19,308 17,498 5,511 17,894 15,515
EBIT 1 8,199 17,426 19,830 19,442 16,785 4,725 16,995 15,375
Net income 1 3,439 -9,015 6,994 6,327 8,025 -6,295 9,423 9,635
Net Debt 1 31,340 34,412 27,587 30,067 27,128 37,744 29,549 22,589
Reference price 2 64.19 62.03 62.35 71.95 51.31 57.04 57.04 57.04
Nbr of stocks (in thousands) 2,344,185 2,259,752 2,219,645 2,219,645 2,034,758 2,028,177 2,028,177 -
Announcement Date 2/6/20 2/4/21 2/4/22 2/2/23 2/2/24 - - -
1USD in Million2USD
Estimates

P/E ratio, Detailed evolution

Add to a list
Add to a list

0 selected

To use this feature you must be a member
Log inSign up
 P/E ratio EV / Sales EV / EBITDA Yield Capi. ($)
BRISTOL-MYERS SQUIBB COMPANY Stock Bristol-Myers Squibb Company
-18.4x3.23x27.84x+4.19%116B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
59.09x15.25x42.65x+0.70%668B
JOHNSON & JOHNSON Stock Johnson & Johnson
21.39x4.14x12.09x+3.22%357B
NOVO NORDISK A/S Stock Novo Nordisk A/S
25.65x9.11x18.37x+1.91%356B
ABBVIE INC. Stock AbbVie Inc.
38.41x6.48x14.29x+3.61%305B
MERCK & CO., INC. Stock Merck & Co., Inc.
13.66x4.16x9.93x+3.17%243B
ROCHE HOLDING AG Stock Roche Holding AG
16.46x3.83x9.99x+3.65%240B
ASTRAZENECA PLC Stock AstraZeneca PLC
25.53x4.38x13.82x+2.28%211B
NOVARTIS AG Stock Novartis AG
17.72x4.19x10.68x+3.80%197B
PFIZER, INC. Stock Pfizer, Inc.
15.17x3.32x8.43x+6.26%151B
Average 21.47x 5.81x 16.81x +3.28% 284.35B
Weighted average by Cap. 29.64x 7.54x 20.41x +2.71%
See all sector valuations

Income Statement and Estimates

income-statement-evolution-chart BRISTOL-MYERS-SQUIBB-COMP More financial data

Year-on-year evolution of the PER

evolution-chart BRISTOL-MYERS-SQUIBB-COMP

Historical PBR trend

evolution-chart BRISTOL-MYERS-SQUIBB-COMP

Evolution Enterprise Value / Sales

evolution-chart BRISTOL-MYERS-SQUIBB-COMP

Change in Enterprise Value/EBITDA

evolution-chart BRISTOL-MYERS-SQUIBB-COMP

Year-on-year evolution of the Yield

evolution-chart BRISTOL-MYERS-SQUIBB-COMP
  1. Stock Market
  2. Equities
  3. BMY Stock
  4. Valuation Bristol-Myers Squibb Company